ITRM
Iterum Therapeutics PLC
NASDAQ: ITRM · HEALTHCARE · BIOTECHNOLOGY
$0.03
+0.00% today
Updated 2026-04-29
Market cap
$3.75M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $1
Volume
32.7M
Iterum Therapeutics PLC (ITRM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $508000.00 | $869000.00 | $37000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | +71.1% | -95.7% | -100.0% | — | — | — | — |
| Cost of revenue | $0.00 | $29.90M | $0.00 | — | $161000.00 | $2.10M | $1.80M | $1.75M | $254000.00 |
| Gross profit | $0.00 | $508000.00 | $869000.00 | $37000.00 | $-161000.00 | $-2.10M | $-1.80M | $-1.75M | $-254000.00 |
| Gross margin | — | 100.0% | 100.0% | 100.0% | — | — | — | — | — |
| R&D | $10.10M | $25.50M | $68.65M | $90.77M | $20.91M | $8.61M | $15.82M | $38.24M | $10.46M |
| SG&A | $3.26M | $4.46M | $8.78M | $11.28M | $11.05M | $13.82M | $12.77M | $7.48M | $7.98M |
| Operating income | $-13.36M | $-29.45M | $-76.56M | $-102.02M | $-32.13M | $-24.54M | $-30.38M | $-47.47M | $-18.70M |
| Operating margin | — | -5798.2% | -8810.0% | -275732.4% | — | — | — | — | — |
| EBITDA | $-13.35M | $-29.39M | $-76.02M | $-101.67M | $-36.01M | $-83.20M | $-39.97M | $-34.58M | $-21.73M |
| EBITDA margin | — | -5785.4% | -8748.2% | -274791.9% | — | — | — | — | — |
| EBIT | $-26.71M | $-29.45M | $-76.16M | $-101.83M | $-36.17M | $-85.31M | $-41.77M | $-36.33M | $-22.01M |
| Interest expense | $0.00 | $277000.00 | $426000.00 | $861000.00 | $15.10M | $5.55M | $2.36M | $1.43M | $2.52M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13.46M | $-29.41M | $-77.06M | $-103.13M | $-52.01M | $-91.56M | $-44.43M | $-38.37M | $-24.77M |
| Net income growth (YoY) | — | -118.4% | -162.0% | -33.8% | +49.6% | -76.1% | +51.5% | +13.6% | +35.4% |
| Profit margin | — | -5788.6% | -8867.2% | -278729.7% | — | — | — | — | — |